Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
Title
Grant Type
Focus Area
Country
Application Due Date
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Biosimilars in Hematologic Malignancies & Supportive Care
Release Date:
Review Process: Pfizer Internal
Education Oncology All
The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Advances in Atopic Dermatitis for Advanced Practitioners
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
2020 RD US- Next Generation PET Imaging for ATTR-CM
Release Date:
Partner: GE Healthcare
Review Process: Expert Review Panel
Research Rare Disease USA
Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant Program
Release Date:
Partner: International Society of Amyloidosis
Review Process: Expert Review Panel
Fellowship Rare Disease All
Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence Treatment
Release Date:
Partner: Mayo Clinic/Global Bridges
Review Process: Expert Review Panel
Education Internal Medicine China, Malaysia, Taiwan, Thailand
4th Quality Improvement initiatives optimizing AF and VTE management in Canada
Release Date:
Partner: Bristol-Myers Squibb
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Canada
2021 Rheumatology Competitive Grant Program
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA